Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02295956 · ClinicalTrials.gov registry record · Early Phase 1

Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer

A Early Phase 1 study of Pancreatic Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
Early Phase 1
Development phase
75
Enrollment target
2
Study locations

NCT02295956: Completed Early Phase 1 study of Pancreatic Cancer, sponsored by M.D. Anderson Cancer Center.

NCT02295956 is a Early Phase 1 study of Pancreatic Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 75 participants, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02295956, a Early Phase 1 study of Pancreatic Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
Early Phase 1
Development phase
75 participants
Enrollment target
2
Study locations

Study Summary

The goal of this research study is to learn if it is possible to start a home-based exercise and nutrition program for patients with pancreatic cancer or who may have pancreatic cancer before surgery (pre-operative rehabilitation, also known as prehabilitation).

Primary Outcome

Feasibility established if \> 60% of patients are adherent. Prehabilitation program deemed feasible if 60% or more of participants complete at least 60% of the weekly 150-minute combined walking and strengthening exercises during the 6-week preoperative period.

Conditions Studied

Interventions

  • OTHER Exercise
  • BEHAVIORAL Questionnaires
  • OTHER Booklet
  • BEHAVIORAL Phone Calls
  • OTHER Nutrition Counseling

Study Locations (2)

Texas

  • University of Houston - Houston
  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2015-02-02
Est. Completion 2019-06-06
Phase Early Phase 1
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT02295956 record still lists

NCT02295956 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 393-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Pancreatic Cancer appearing as the primary indexed condition, and to 5 interventions - of which Exercise is the first listed.

NCT02295956 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02295956 about?

NCT02295956 is a clinical study titled "Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer". The goal of this research study is to learn if it is possible to start a home-based exercise and nutrition program for patients with pancreatic cancer or who may have pancreatic cancer before surgery (pre-operative rehabilitation, also known as prehabilitation).

What is the current status of trial NCT02295956?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 75 participants. The study started on 2015-02-02. Estimated completion is 2019-06-06.

What conditions does trial NCT02295956 study?

This clinical trial studies the following conditions: Pancreatic Cancer.

What interventions are being tested in trial NCT02295956?

The interventions under investigation include: Exercise (OTHER), Questionnaires (BEHAVIORAL), Booklet (OTHER), Phone Calls (BEHAVIORAL), Nutrition Counseling (OTHER).

Who is sponsoring clinical trial NCT02295956?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02295956 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreatic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02295956's enrollment target sits among peer trials

75 128th of 278 higher than 150 of 278 other Pancreatic Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pancreatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02295956, the US trial registry maintained by the National Library of Medicine. NCT02295956 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.